BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23480042)

  • 1. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
    Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
    Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
    Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
    Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
    Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937.
    Amo T; Kawanishi N; Uchida M; Fujita H; Oyanagi E; Utsumi T; Ogino T; Inoue K; Shuin T; Utsumi K; Sasaki J
    Cell Biochem Funct; 2009 Dec; 27(8):503-15. PubMed ID: 19735078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
    Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
    J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
    van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
    J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive apoptotic cell death of human glioma cells via a mitochondrial pathway following 5-aminolevulinic acid-mediated photodynamic therapy.
    Inoue H; Kajimoto Y; Shibata MA; Miyoshi N; Ogawa N; Miyatake S; Otsuki Y; Kuroiwa T
    J Neurooncol; 2007 Jul; 83(3):223-31. PubMed ID: 17245620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
    Mansi M; Howley R; Chandratre S; Chen B
    Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.
    Palasuberniam P; Kraus D; Mansi M; Braun A; Howley R; Myers KA; Chen B
    Photochem Photobiol; 2019 Jul; 95(4):1052-1059. PubMed ID: 30767226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
    Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
    J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.
    Mansi M; Howley R; Chen B
    Methods Mol Biol; 2022; 2394():823-835. PubMed ID: 35094360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin.
    Iinuma S; Farshi SS; Ortel B; Hasan T
    Br J Cancer; 1994 Jul; 70(1):21-8. PubMed ID: 8018536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
    Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
    Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
    Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
    Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer.
    Nakayama T; Nozawa N; Kawada C; Yamamoto S; Ishii T; Ishizuka M; Namikawa T; Ogura SI; Hanazaki K; Inoue K; Karashima T
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101893. PubMed ID: 32592910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.
    Anand S; Wilson C; Hasan T; Maytin EV
    Cancer Res; 2011 Sep; 71(18):6040-50. PubMed ID: 21807844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
    Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.